Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

Home About Us Hasumi International Research Foundation

Tuesday26 March 2019

Hasumi International Research Foundation

Hasumi International Research Foundation (HIRF)

Hasumi International Research Foundation (HIRF) was incorporated as a nonprofit organization in 1999 in collaboration with the Thomas Jefferson University in Philadelphia, United States of America; an respected and renowned academic research institute that pioneered many immunotherapy research.

HIRF’s main office has since moved to its current location in Washington DC in 2002. The Hasumi Foundation continues to be supported by public and private funds to further its cancer research program and activities.

The main objective of the HIRF is to conduct and support scientific research in connection with finding a cure for various forms of cancer with special focus in the field of immunotherapy. One of its mission is to develop a highly sophisticated database and network system for the collection and dissemination of valuable data from cancer research and treatment throughout the world.

Currently, HIRF is supporting cancer research and related program/activities in the United States, Japan, Taiwan, China, Bulgaria, Singapore and Malaysia.


HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks